Cleared Traditional

K860476 - ACID PHOSPHATASE REAGENT SET

K860476 is the FDA 510(k) clearance for ACID PHOSPHATASE REAGENT SET by Sterling Diagnostics, Inc.. It is a Class 2 Chemistry device (product code CKE) cleared through the Traditional 510(k) pathway after a 26-day FDA review.

K860476 · Sterling Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1986
Decision
26d
Days
Class 2
Risk

K860476 is an FDA 510(k) clearance for the ACID PHOSPHATASE REAGENT SET. Classified as Acid Phosphatase, Thymolphthale Inmonophosphate (product code CKE), Class II - Special Controls.

Submitted by Sterling Diagnostics, Inc. (Sterling Heights, US). The FDA issued a Cleared decision on March 5, 1986 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1020 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sterling Diagnostics, Inc. devices

Submission Details

510(k) Number K860476 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 1986
Decision Date March 05, 1986
Days to Decision 26 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 88d · This submission: 26d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CKE Acid Phosphatase, Thymolphthale Inmonophosphate
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1020
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CKE Acid Phosphatase, Thymolphthale Inmonophosphate

Devices cleared under the same product code (CKE) and FDA review panel - the closest regulatory comparables to K860476.
CLINICAL CHEM.ANAL.ACID,PROSTATIC ACID PHOSPHATASE
K914167 · Eastman Kodak Company · Mar 1992
ACID PHOSPHATASE TEST
K873726 · King Diagnostics, Inc. · Jan 1988
DIMENSION (TM) CLINICAL CHEMISTRY SYSTEM
K864230 · E.I. Dupont DE Nemours & Co., Inc. · Nov 1986
ACID PHOSPHATASE ASSAY KIT
K843380 · Diagnostic Chemicals, Ltd. (Usa) · Sep 1984
STANBIO PROSTATIC ACID PHOSPHATASE TEST
K800693 · Stanbio Laboratory · Apr 1980
DATA-ZYME ACIA PHOSPHATASE PROCEDURE
K790524 · Data Medical Associates, Inc. · May 1979